Theravance Biopharma
TBPH
TBPH
128 hedge funds and large institutions have $422M invested in Theravance Biopharma in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 119 → 128 (+9)
2.26% less ownership
Funds ownership: 93.55% → 91.29% (-2.3%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
128
Holding in Top 10
3
Calls
$11K
Puts
$3K
Top Buyers
| 1 | +$2.43M | |
| 2 | +$1.35M | |
| 3 | +$897K | |
| 4 |
Millennium Management
New York
|
+$754K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$753K |
Top Sellers
| 1 | -$5.55M | |
| 2 | -$1.3M | |
| 3 | -$974K | |
| 4 |
Jane Street
New York
|
-$868K |
| 5 |
AG
Algert Global
San Francisco,
California
|
-$851K |